0001209191-23-031518.txt : 20230522 0001209191-23-031518.hdr.sgml : 20230522 20230522170509 ACCESSION NUMBER: 0001209191-23-031518 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230518 FILED AS OF DATE: 20230522 DATE AS OF CHANGE: 20230522 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Rosenberg Adam Joseph CENTRAL INDEX KEY: 0001867407 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40708 FILM NUMBER: 23945453 MAIL ADDRESS: STREET 1: C/O ELIEM THERAPEUTICS, INC. STREET 2: 23515 NE NOVELTY HILL RD, STE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Eliem Therapeutics, Inc. CENTRAL INDEX KEY: 0001768446 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 832273741 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 23515 NE NOVELTY HILL ROAD STREET 2: SUITE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 BUSINESS PHONE: 877-354-3689 MAIL ADDRESS: STREET 1: 23515 NE NOVELTY HILL ROAD STREET 2: SUITE B221 #125 CITY: REDMOND STATE: WA ZIP: 98053 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-05-18 0 0001768446 Eliem Therapeutics, Inc. ELYM 0001867407 Rosenberg Adam Joseph C/O ELIEM THERAPEUTICS, INC. 23515 NE NOVELTY HILL RD, STE. B221 #125 REDMOND WA 98053 1 0 0 0 0 Common Stock 178100 D Stock Option (Right To Buy) 3.00 2023-05-18 4 A 0 10000 0.00 A 2033-05-17 Common Stock 10000 10000 D The shares subject to the option will vest on the earlier of May 18, 2024 or the day immediately prior to the next annual meeting of stockholders, subject to the Reporting Person's continuous service through such date. /s/ Brian Woodard, Attorney-in-Fact 2023-05-22